IJ Pharmaceutical Research
Crossref
1. Unraveling the Exosome-miR-133a Axis: Targeting TGF-β Signaling via WJ-MSC-Derived Exosomes for Anti-Fibrotic Therapy in Liver Fibrosis
- Sahar Saki
- Sajad Monjezi
- Fatemeh Ghaffari
- Ghazal Orak
- Samaneh Salehipour Bavarsad
- Azam Khedri
- Mahdi Hatami
2. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
- Yan Jiang
- Narazah Mohd Yusoff
- Jiang Du
- Emmanuel Jairaj Moses
- Jun-Tang Lin
3. Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review
- Yanling Qu
- Zhe Wang
- Lingjuan Dong
- Dan Zhang
- Fengqing Shang
- Afeng Li
- Yanni Gao
- Qinhua Bai
- Dan Liu
- Xiaodong Xie
- Leiguo Ming
4. Anti-fibrotic Potential of WJ-MSC Exosomes in Liver Fibrosis: Mechanistic Insights and Dose-Response Efficacy
- Azam Khedri
- Mohammadreza Roshanazadeh
- Mahdi Hatami
- Arash Sanaei
- Sahar Saki
- Samaneh Salehipour Bavarsad
5. Three-Dimensional Bioprinting of Tarsal Plates with Adipose-Derived Mesenchymal Stem Cells: Evaluation of Meibomian Gland Reconstruction in a Rat Model
- Hyunkyu Lee
- Yoon Hee Park
- Hyo Jin Kang
- Hwa Lee
6. Regulatory, diagnostic, and therapeutic roles of microRNAs in chronic liver diseases
- Razieh Kazemzadeh
- Maryam Kheirollahi
- Seyed Ali Mard
- Akram Ahangarpour
- Feryal Savari
7. USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway
- Yanjin Wang
- Chen Wang
- Fuji Yang
- Yifei Chen
- Yujie Shi
- Ruizi Xu
- Zhuan Zhang
- Yongmin Yan
8. Biocompatible Poly(ε-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin
- Floriana D’Angeli
- Giuseppe Granata
- Ivana Roberta Romano
- Alfio Distefano
- Debora Lo Furno
- Antonella Spila
- Mariantonietta Leo
- Chiara Miele
- Dania Ramadan
- Patrizia Ferroni
- Giovanni Li Volti
- Paolo Accardo
- Corrada Geraci
- Fiorella Guadagni
- Carlo Genovese